Inactivation of p16 by CpG hypermethylation in renal cell carcinoma

Of the molecular modifications described for renal carcinoma, aberrations in the p16 gene are frequent. In these patients, methylation of the p16 gene promoter seems to afford a protective effect against the risk of death.